Melissa R. Miller, PhD, is a Senior Director of Human Genetics in the Internal Medicine Research Unit at Pfizer.  Melissa and her team use human genetics and statistical genetics methods to help identify and prioritize targets to support the discovery of new medicines to address unmet medical needs in cardiovascular and metabolic diseases. Melissa leads or has been involved in several pre-competitive consortia including co-founding the UK Biobank Pharma Proteomics Consortium, the UK Biobank whole exome sequencing consortium, co-chair of the AMP Common Metabolic diseases program, and member of the Accelerating Medicines Partnership (AMP) Type 2 Diabetes (T2D). Melissa joined Pfizer in 2014.  Prior to joining Pfizer, Melissa completed her PhD in Epidemiology at the University of Colorado and completed a post-doctoral fellowship in statistical genetics and genetic epidemiology at the Hospital for Sick Children in Toronto.